Broadening the field of opportunity for medicinal chemists. Official journal of the European Federation for Medicinal Chemistry
Impact Factor 2.626 12 Issues per Year
Concise Article

De novo design, synthesis and pharmacological evaluation of new azaindole derivatives as dual inhibitors of Abl and Src kinases

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
OriBase Pharma, Cap Gamma, 1682 rue de la Valsière, CS17383, 34189 Montpellier, France
E-mail: ayasri@oribase-pharma.com;
Fax: +33 (0)467 72 76 79 ;
Tel: +33 (0)467 72 76 70
Med. Chem. Commun., 2012,3, 788-800

DOI: 10.1039/C2MD20104F
Received 28 Jan 2012, Accepted 06 May 2012
First published online 19 Jun 2012
| | | | | | More
Please wait while Download options loads
Download Citation